Showing 501 - 520 results of 1,266 for search '"Lung cancer"', query time: 0.08s Refine Results
  1. 501

    Metastatic Non-Small-Cell Lung Cancer in the Setting of Unilateral Agenesis of the Left Pulmonary Artery: A Case Report and Comprehensive Literature Review by John Agzarian, Jakub Kadlec, Lori Whitehead, Yaron Shargall

    Published 2019-01-01
    “…We present the first reported case of ipsilateral metastatic non-small-cell lung cancer- (NSCLC-) associated UAPA in a 47-year-old patient with ventilator-dependent hypoxic respiratory failure and bronchorrhea, who had been lost to follow-up for 8 years. …”
    Get full text
    Article
  2. 502

    Transcription Expression and Clinical Significance of Dishevelled-3 mRNA and δ-Catenin mRNA in Pleural Effusions from Patients with Lung Cancer by Xiao-Yan Li, Shu-Li Liu, Na Cha, Yu-Jie Zhao, Shao-Cheng Wang, Wei-Nan Li, En-Hua Wang, Guang-Ping Wu

    Published 2012-01-01
    “…To evaluate diagnostic utility of Dishevelled-3 (DVL-3) mRNA and δ-catenin mRNA expression in pleural effusions of patients with lung cancer. Methods. DVL-3 mRNA and δ-catenin mRNA levels were assessed by performing RT-PCR on pleural effusion specimens from patients with lung cancer (n=75) and with lung benign disease (n=51). …”
    Get full text
    Article
  3. 503
  4. 504
  5. 505
  6. 506
  7. 507

    Association between advanced lung cancer inflammation index and all-cause and cause-specific mortality among asthma patients: a cohort study by Tu-Lei Tian, Xiang-Kun Qu, Hong-Bo Zhang, Cun-Cun Wang, Qing-Qing Yuan, Jing Xia, Li-Fang Cao, Kui Liu

    Published 2025-02-01
    “…BackgroundThe advanced lung cancer inflammation index (ALI), which reflects both inflammation and nutritional status, has an uncertain role in predicting outcomes for asthma patients. …”
    Get full text
    Article
  8. 508

    A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients by Eleni-Kyriaki Vetsika, Filippos Koinis, Marianthi Gioulbasani, Despoina Aggouraki, Anna Koutoulaki, Eirini Skalidaki, Dimitris Mavroudis, Vassilis Georgoulias, Athanasios Kotsakis

    Published 2014-01-01
    “…The presence of phenotypically newly described subpopulations of MDSCs and their association with the clinical outcome were investigated in non-small cell lung cancer (NSCLC) patients. The percentages and correlation between MDSCs and distinct immune cells in the peripheral blood of 110 chemotherapy-naive patients before treatment and healthy controls were investigated using flow cytometry. …”
    Get full text
    Article
  9. 509
  10. 510
  11. 511
  12. 512

    Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study by Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang

    Published 2019-03-01
    “…Interventions Targeted therapies have been proven to provide clinical benefits to patients with metastatic non-small cell lung cancer (NSCLC). Gefitinib was initially approved and reimbursed as a third-line therapy for patients with advanced NSCLC by the Taiwan National Health Insurance (NHI) in 2004; subsequently it became a second-line therapy (in 2007) and further a first-line therapy (in 2011) for patients with epidermal growth factor receptor mutation-positive advanced NSCLC. …”
    Get full text
    Article
  13. 513
  14. 514

    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Accuracy in the Staging of Non-Small Cell Lung Cancer: Review and Cost-Effectiveness by Nieves Gómez León, Sofía Escalona, Beatriz Bandrés, Cristobal Belda, Daniel Callejo, Juan Antonio Blasco

    Published 2014-01-01
    “…Aim of the performed clinical study was to compare the accuracy and cost-effectiveness of PET/CT in the staging of non-small cell lung cancer (NSCLC). Material and Methods. Cross-sectional and prospective study including 103 patients with histologically confirmed NSCLC. …”
    Get full text
    Article
  15. 515

    NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target by Hongbo Huang, Qingwang Hua

    Published 2022-01-01
    “…Nei endonuclease VIII-like 3 (NEIL3) is widely involved in pathophysiological processes of the body; however, its role in lung cancer has not been conclusively determined. Objective. …”
    Get full text
    Article
  16. 516

    Diagnostic role of circulating long non-coding RNA LINC00312 in patients with non-small cell lung cancer: a retrospective study by Ruoqian Zhang, Yan Jiang, Jing Gu, Xilin Zhang, Yanping Xie

    Published 2025-01-01
    “…Abstract Background LINC00312 has shown to play a suppressive role in the development and progression of non-small cell lung cancer (NSCLC). However, the expression pattern and diagnostic role of circulating LINC00312 in NSCLC remain to be confused. …”
    Get full text
    Article
  17. 517

    Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy by Yuanshan Yao, Chunji Chen, Bin Li, Wen Gao

    Published 2025-02-01
    “…This study aims to explore the role of HVEM in non-small cell lung cancer (NSCLC) microenvironment. Methods The lung cancer datasets for this study were directly downloaded from The Cancer Genome Atlas (TCGA). …”
    Get full text
    Article
  18. 518
  19. 519
  20. 520